Sorafenib
targeted anticancer therapy · kinase inhibitor
Nothing to addWhat this medicine is for
Sorafenib belongs to the category “targeted anticancer therapy (kinase inhibitor)”. This targeted therapy attacks a specific mechanism of tumor cells; it falls under a specialized hospital prescription.
In the case of Sorafenib, this means: Treats a cancer by targeting tumour cells. It is part of specialised, closely monitored care.
Under which brands it is found
In France, about 8 reimbursable presentations containing Sorafenib are recorded. It comes under various trade names and in generic form.
- Nexavar
- Sorafenib Accord
- Sorafenib Biogaran
- Sorafenib Eg
- Sorafenib Sandoz
- Sorafenib Teva
- Sorafenib Viatris
- Sorafenib Zentiva
Original brand-name products and generics deliver the same active substance; the choice between them is made with your doctor or pharmacist.
Do you need a supplement? No.
We put forward no supplement for Sorafenib: that would be forcing a need that does not exist. The great majority of medicines call for no particular supplementation, and acknowledging this is part of the way we work. We design a supplement only where the data support it, across five specific classes.
Talk about it in the community
Members are already discussing the topic: sensations, doubts, everyday tips. People speak frankly here, without lecturing or prescribing.
Related molecules
To explore in the « Other areas » family and its neighbours.